172 related articles for article (PubMed ID: 17854304)
1. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
Estes DA; Lovato DM; Khawaja HM; Winter SS; Larson RS
Br J Haematol; 2007 Oct; 139(1):20-30. PubMed ID: 17854304
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
3. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
4. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
5. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
[TBL] [Abstract][Full Text] [Related]
7. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
Chiu LY; Ko JL; Lee YJ; Yang TY; Tee YT; Sheu GT
Toxicol Lett; 2010 Feb; 192(3):408-18. PubMed ID: 19944135
[TBL] [Abstract][Full Text] [Related]
8. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent.
Winter SS; Lovato DM; Khawaja HM; Edwards BS; Steele ID; Young SM; Oprea TI; Sklar LA; Larson RS
J Biomol Screen; 2008 Mar; 13(3):185-93. PubMed ID: 18310528
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous targeting of MCL1 and ABCB1 as a novel strategy to overcome drug resistance in human leukaemia.
Ji M; Li J; Yu H; Ma D; Ye J; Sun X; Ji C
Br J Haematol; 2009 Jun; 145(5):648-56. PubMed ID: 19344413
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in chemoresistant variants of three cell lines of different origin.
Johnsson A; Vallon-Christensson J; Strand C; Litman T; Eriksen J
Anticancer Res; 2005; 25(4):2661-8. PubMed ID: 16080509
[TBL] [Abstract][Full Text] [Related]
12. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
13. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M
Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732
[TBL] [Abstract][Full Text] [Related]
14. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
[TBL] [Abstract][Full Text] [Related]
15. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
[TBL] [Abstract][Full Text] [Related]
17. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
19. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.
Watanabe A; Inukai T; Kagami K; Abe M; Takagi M; Fukushima T; Fukushima H; Nanmoku T; Terui K; Ito T; Toki T; Ito E; Fujimura J; Goto H; Endo M; Look T; Kamps M; Minegishi M; Takita J; Inaba T; Takahashi H; Ohara A; Harama D; Shinohara T; Somazu S; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2019 Sep; 8(11):5274-5288. PubMed ID: 31305009
[TBL] [Abstract][Full Text] [Related]
20. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
